Month: July 2016
-
High-Volume, More Efficient Stem Cell Production Developed
An academic-industry team in Europe designed and tested new processes that can simplify and streamline production of human stem cells in large quantities.
-
Technique Devised for 3-D Alzheimer’s Brain Images
Researchers in New York applied an imaging technique that visualizes the build-up of amyloid-beta plaques in the brain associated with Alzheimer’s disease.
-
Refillable HIV Prevention Implant in Development
A device implanted under the skin providing 60 days of antiretroviral drugs to prevent HIV infection is in development at Houston Methodist Research Institute.
-
23andMe Offering Genetic Analysis Service for Researchers
23andMe is offering a new analytical service for researchers that determines genotypes, or genetic variations, of individuals taking part in their studies.
-
Danforth Center, Valent Partner on Underground Plant Imaging
A plant science center and crop science company are developing a large-scale X-ray imaging system to measure root development in plants.
-
Pomegranate Molecule Found With Anti-Aging Benefits
A study in Switzerland finds ingredients in pomegranates, once metabolized in the gut, protect cells against aging, in tests with lab mice.
-
FDA Approves MRI, Ultrasound Device for Tremors
FDA approved for marketing a device that combines ultrasound and MRI to treat essential tremors, a disorder marked by involuntary shaking of the hands.
-
Company, Charity to Discover Antibiotic Boosters
An organization promoting research on drug-resistant bacteria is collaborating with a drug discovery company on compounds that reverse antibiotic resistance.
-
American Heart Assn, Amazon Partner on Cloud Analytics
American Heart Association is offering grants for new computational tools against heart disease, with Amazon Web Services providing cloud computing resources.
-
Leukemia T-Cell Trial Stopped After Patients’ Deaths
FDA halted a clinical trial testing engineered T-cells as a treatment for leukemia, after 3 participants died. Update: Juno to resume engineered T-cell trial.